July 20, 2010 – InfraScan announced this week that it has signed a $2 million contract with the U.S. Marine Corps and Navy to develop a next-generation version of the company’s Infrascanner brain hematoma detector.

The Infrascanner is a small, portable device that can detect the presence and location of a brain hematoma based on differential near infrared light absorption of a hematoma and normal brain tissue. It is the first hand-held device designed to assist first responders and emergency room personnel in identifying life threatening brain hematomas and allowing expedient assessment of patients and facilitating crucial treatment.

InfraScan’s proposal was accepted in its entirety, in response to a proposal request by the Naval Health Research Center Broad Agency Announcement. The Small Business Innovation Research (SBIR) Commercialization Pilot Program contract transitions a successful SBIR Phase 2 project initiated by the Office of Naval Research into the hands of the eventual end users in the Marine Corps. The contract is focused on creating a portable device for detection of traumatic brain injuries in operational environments such as battlefields. Head wounds lead to nearly 50 percent of combat deaths.

In the battlefield setting, it is necessary to triage patients with severe injuries. Intracranial hematomas resulting from a traumatic brain injury are life-threatening and patient outcomes can improve significantly if treated within an hour after an injury – known as the “golden hour.” While most U.S. hospitals have a computer aided tomography (CAT) scanner, which is viewed as the state-of-the-art technology for diagnosing a brain hematoma, remote battlefields and many facilities lack the neurosurgical capabilities to treat the condition. The early identification of a brain hematoma can play a significant role in facilitating transportation of critically injured patients to facilities, which can both verify Infrascanner’s early screening and offer surgical intervention.

For more information: www.infrascanner.com


Related Content

News | Ultrasound Imaging

April 22, 2024 — GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which ...

Time April 22, 2024
arrow
News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 17, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with the ...

Time April 17, 2024
arrow
News | ACR

April 15, 2023 — The American College of Radiology (ACR) released an update to its ACR Appropriateness Criteria (ACR AC) ...

Time April 13, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 10, 2024 — Online MRI and CT education leader, ImagingU, announced the launch of a new course for students and ...

Time April 10, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
News | Radiation Dose Management

April 9, 2024 — Mirion Dosimetry Services, a Mirion Medical company, today announced commercial availability of its ...

Time April 09, 2024
arrow
News | Ultrasound Imaging

April 9, 2024 — A new Society of Radiologists in Ultrasound (SRU) expert consensus statement to improve endometriosis ...

Time April 09, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 8, 2024 — Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive technique for neuroregulation ...

Time April 08, 2024
arrow
Subscribe Now